Free Trial
→ DeepSeek’s Clear and Present Danger (From Brownstone Research) (Ad) Buy ATOS Stock  Free ATOS Stock Alerts

Atossa Therapeutics (ATOS) SEC Filings & 10K Form

Atossa Therapeutics logo
$0.73 -0.01 (-0.73%)
As of 04:00 PM Eastern
Compare

Recent Atossa Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/26/2025
3:40 PM		Atossa Therapeutics (Filer)
Form ARS
03/26/2025
3:30 PM		Atossa Therapeutics (Filer)
Form DEF 14A
03/25/2025
7:05 AM		Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
7:10 AM		Atossa Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2025
8:00 AM		Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
3:05 PM		Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:09 PM		Atossa Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G/A
02/04/2025
8:00 AM		Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:05 AM		Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
12:32 PM		Atossa Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:27 AM		Atossa Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
5:35 AM		Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM		Atossa Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/12/2024
8:00 AM		Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
8:05 AM		Atossa Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/23/2024
11:15 PM		Atossa Therapeutics (Filer)
Form EFFECT
05/23/2024
8:00 AM		Atossa Therapeutics (Filer)
Form DEF 14A
05/14/2024
3:46 PM		Atossa Therapeutics (Filer)
Form DEL AM
05/13/2024
8:00 AM		Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
8:05 AM		Atossa Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
8:00 AM		Atossa Therapeutics (Filer)
Form PRE 14A
05/10/2024
8:04 AM		Atossa Therapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ATOS) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners
James Altucher: Do not invest in AI unless…
I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...
Paradigm Press | Sponsored
Trump’s treachery
Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...
Porter & Company | Sponsored
Two Unmistakable Patterns Return…
The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...
Golden Portfolio | Sponsored
The Collapse Is Already Here
When a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...
Investors Alley | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...
Crypto Swap Profits | Sponsored
Do this Before Elon's Reveal on April 23rd
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...
Brownstone Research | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored